Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': A randomised, double-blind comparative trial in Asian patients

Journal of Human Hypertension

Volumn 16, Issue 11, 2002, Pages 805-813

  Ongtengco, I ^a   Morales, D ^b   Sanderson, J ^c   Lu, Z R ^d   Beilin, L J ^e   Burke, V ^e   Puddey, I B ^e   Tanomsup, S ^f   Dayi, H ^g   Rahardjo, P ^h   Zambahari, Dato R ⁱ   Chen, C Y ^j   Soenarta, A A ^k   Buranakitjaroen, P ^l   Tan, C ^m   Soon, T K ⁿ   Wu, D J ^o  

^a ST LUKE S MEDICAL CENTER   (Philippines)

^b Manila Doctors Hospital   (Philippines)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d XI'AN MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f MAHIDOL UNIVERSITY   (Thailand)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

ⁱ NATIONAL HEART INSTITUTE   (Malaysia)

^j KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^k NATIONAL CARDIOVASCULAR CENTER HARAPAN KITA   (Indonesia)

^l MAHIDOL UNIVERSITY   (Thailand)

^m HOSPITAL KUALA LUMPUR   (Malaysia)

ⁿ CHANGI GENERAL HOSPITAL   (Singapore)

^o CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

more..

Author keywords

Amlodipine; Efficacy; Essential hypertension; Medication compliance; Missed doses; Nifedipine GITS

Indexed keywords

AMLODIPINE; ANALGESIC AGENT; ANTIGOUT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; NIFEDIPINE; PLACEBO; VITAMIN;

ABDOMINAL PAIN; ADULT; AGED; ALLERGY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASIAN; BACTERIAL INFECTION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIGESTIVE SYSTEM DISEASE; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; GOUT; HEADACHE; HEART PALPITATION; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYALGIA; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PAIN; PARALLEL DESIGN; PATIENT COMPLIANCE; PATIENT SELECTION; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; POLYURIA; PROTECTION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN APPENDAGE DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE; VERTIGO; VITAMIN DEFICIENCY;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ASIA, SOUTHEASTERN; BLOOD PRESSURE MONITORING, AMBULATORY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPERTENSION; NIFEDIPINE;

EID: 0036865960     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001485     Document Type: Article

References (24)

1. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the US Joint Natinal Committee on Prevention Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
2. World Health Organization - International Society of Hypertension (ISH). 1999. World Health Organization - International society of Hypertension Guidelines for the management of Hypertension. J Hypertens 1999; 17: 151-183.
3. Ramsay L et al. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-592.
4. Meredith PA. The importance of sustained blood pressure control. J Cardiovasc Pharmacol 2000; 35 (Suppl 3): S7-S11.
5. Mancia G et al. for the SAMPLE Study Group. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95: 1464-1470.
6. McInnes GT. Integrated approaches to management of hypertension: Promoting treatment acceptance. Am Heart J 1999; 138 (part 2): 252-255.
7. Burnier M. Long-term compliance with antihypertensive therapy: Another facet of chornotherapeutics in hypertension. Blood Press Monti 2000; 5 (Suppl 1): S31-S34.
8. Trilling JS, Froom J. The urgent need to improve hypertension care. Arch Fam Med 2000; 9: 794-801.
9. Williams GH. Assessing patient wellness: New perspectives on quality of life and compliance. Am J Hypertens 1998; 11 (Part 2): 186S-191S.
10. Rudd P. Compliance with antihypertensive therapy: Raising the bar of expectations. Am J Manag Care 1998; 4: 957-966.
11. Mallion JM et al. Compliance, electronic monitoring and antihypertensive drug. J Hypertens 1998; 16: (Suppl 1): S75-S79.
12. Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: Is drug choice a factor in treatment adherence? Curr Hypertens Rep 2002; 2: 515-524.
13. Haria M, Wagstaff AJ. Amlodipine: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs 1995; 50: 560-586.
14. Brogden RN, McTavish D. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris. Drugs 1995; 50: 495-512.
15. Mancia G et al. Relation between blood pressure variability and carotid artery damage in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 2001; 19: 1981-1989.
16. Ueda S et al. A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects. Br J Clin Pharmacol 1993; 36: 561-566.
17. Zanchetti A et al. Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertensives. J Hypertens 1993; 11 (Suppl 5): s334-s335.
18. Zanchetti A et al. Antihypertensive effects of nifedipine GITS on clinic and ambulatory blood pressure in essential hypertensive. High Blood Press 1994; 3: 45-56.
19. Ferruci et al. 24-blood pressure profiles in patients with hypertension treated with amlodipine or nifedipine GITS. Clin Drug Invest 1997; 13(Suppl 1): 67-72.
20. Elliott HL. Persistence of antihypertensive efficacy after missed doses: Comparison of amlodipine and nifedipine GITS [abstract]. J Hypertens 1997; 15(Suppl 4): 8B7.
21. Nussinovitch N, Rosenberg G, Peleg E, Rosenthal T. A comparative crossover evaluation of amlodipine and nifedipine GITS before and after a missed dose: 48-h blood pressure profiles. Am J Hypertens 2002; 15: 580-582.
22. Motero J et al. Long acting calcium channel blockers in hypertension. Amlodipine vs nifedipine GITS comparative study. Am J Hypertens 1998; 11: 69A.
23. Hernandez-Hernandez R et al. The effects of a missing dose of enalapril versus amlodipine on ambulatory blood pressure. Blood Press Monit 1996; 1: 121-126.
24. Leenen FH, Fourney A, Notman G, Tanner J. Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life. Br J Clin Pharmacol 1996; 41: 83-88.